VanEck Vectors Profile

129.46
USD 0.06  0.0464%
43%
46%

VanEck Vectors Summary

VanEck Vectors Biotech ETF [BBH] is traded in USA and was established on August 21, 2018. The fund is classified under Sector category within Van Eck family. VanEck Vectors Biotech ETF currently have 471.89 M in assets under management (AUM). , while the total return for the last 3 years was -3.96%.
Check VanEck Vectors Probability Of Bankruptcy

Geographic Allocation (%)

Sector Allocation (%)

VanEck Vectors Biotech Currency Exposure (%)

 % of ETF 
      Currency 

Target Price Odds Analysis

Odds Below 129.46HorizonTargetOdds Above 129.46
53.29%30 days 129.46 45.48%
Based on normal probability distribution, the odds of VanEck Vectors to move above current price in 30 days from now is about 45.48% (This VanEck Vectors Biotech ETF probability density function shows the probability of VanEck Vectors Etf to fall within a particular range of prices over 30 days) .

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Ubs Group AgFund Units74.7 K9 M
Susquehanna International Group LlpPut Options11.7 K1.4 M
Susquehanna International Group LlpCall Options10.6 K1.3 M
View VanEck Vectors Diagnostics

VanEck Vectors Biotech Risk Profiles

VanEck Vectors Biotech Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of seventeen. VanEck Vectors Biotech Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe VanEck Vectors price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

Key Fundamentals

VanEck Vectors Against Markets

Current Ratings

VanEck Vectors 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
3 
Chance of
Financial Distress (0 to 100%)
30 
Equity ratings for VanEck Vectors Biotech ETF are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. VanEck Vectors is traded on NASDAQ General Markets in USA. more
NameVanEck Vectors Biotech ETF
ChairmanPhilip HornigView All
Macroaxis Advice
InstrumentUSA Etf View All
RegionGlobal
Investment IssuerVan Eck
ExchangeNASDAQ General Markets
Etf FamilyVan Eck
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Phone800 826 2333
CurrencyUSD - US Dollar
IssuerVan Eck
DescriptionVanEck Vectors Biotech ETF
Inception Date2011-12-20
BenchmarkMV US Listed Biotech 25 NR USD
Entity TypeRegulated Investment Company
Asset Under Management471.89 Million
Average Trading Valume19,299
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionGlobal
AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianThe Bank of New York Mellon Corporation
DistributorVan Eck Securities Corporation
Portfolio ManagerHao-Hung (Peter) Liao, Guo Hua (Jason) Jin
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year EndSeptember 30
ExchangeThe NASDAQ Stock Market LLC
Number of Constituents26.0
Market MakerVirtu Financial
Total Expense0.39
Management Fee0.35
Check also Trending Equities. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.